These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


614 related items for PubMed ID: 17536001

  • 1. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype.
    Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ.
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3001-5. PubMed ID: 17536001
    [Abstract] [Full Text] [Related]

  • 2. Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism.
    Koumakis E, Souberbielle JC, Payet J, Sarfati E, Borderie D, Kahan A, Cormier C.
    Osteoporos Int; 2014 Jul; 25(7):1963-8. PubMed ID: 24676846
    [Abstract] [Full Text] [Related]

  • 3. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism.
    Koumakis E, Souberbielle JC, Sarfati E, Meunier M, Maury E, Gallimard E, Borderie D, Kahan A, Cormier C.
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3213-20. PubMed ID: 23783096
    [Abstract] [Full Text] [Related]

  • 4. Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism.
    Sho S, Kuo EJ, Chen AC, Li N, Yeh MW, Livhits MJ.
    Ann Surg Oncol; 2019 Feb; 26(2):539-546. PubMed ID: 30406488
    [Abstract] [Full Text] [Related]

  • 5. Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.
    Palermo A, Naciu AM, Tabacco G, Falcone S, Santonati A, Maggi D, D'Onofrio L, Briganti SI, Castellitto D, Casini A, Pedone C, Lelli D, Fabbri A, Bilezikian JP, Napoli N, Pozzilli P, Manfrini S, Cesareo R.
    J Clin Endocrinol Metab; 2020 Jul 01; 105(7):. PubMed ID: 32271382
    [Abstract] [Full Text] [Related]

  • 6. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
    Pierreux J, Bravenboer B.
    Horm Metab Res; 2018 Nov 01; 50(11):797-802. PubMed ID: 30396209
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study.
    Rejnmark L, Amstrup AK, Mollerup CL, Heickendorff L, Mosekilde L.
    J Clin Endocrinol Metab; 2013 Jan 01; 98(1):87-96. PubMed ID: 23150677
    [Abstract] [Full Text] [Related]

  • 10. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years.
    Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, Udesky J, Silverberg SJ.
    J Clin Endocrinol Metab; 2008 Sep 01; 93(9):3462-70. PubMed ID: 18544625
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Normocalcemic primary hyperparathyroidism].
    Spivacow FR, Sapag Durán A, Zanchetta MB.
    Medicina (B Aires); 2014 Sep 01; 74(6):457-61. PubMed ID: 25555006
    [Abstract] [Full Text] [Related]

  • 13. Skeletal effects of primary hyperparathyroidism: bone mineral density and fracture risk.
    Lewiecki EM, Miller PD.
    J Clin Densitom; 2013 Sep 01; 16(1):28-32. PubMed ID: 23374738
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Current opinions on nephrolithiasis associated with primary hyperparathyroidism.
    Cong X, Shen L, Gu X.
    Urolithiasis; 2018 Oct 01; 46(5):453-457. PubMed ID: 29350243
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Systems-Level Opportunities in the Management of Primary Hyperparathyroidism: An Informatics-based Assessment.
    Dawood NB, Tseng CH, Nguyen DT, Yan KL, Livhits MJ, Leung AM, Yeh MW.
    J Clin Endocrinol Metab; 2021 Nov 19; 106(12):e4993-e5000. PubMed ID: 34313755
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.